Novo Holdings A/S’s IO Biotech IOBT Stock Holding History

Novo Holdings A/S’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,512,453	Closed	-$1.53M	–	24
2025 Q4	$1.53M	Hold	2,512,453	–	–	0.12%	24
2025 Q3	$912K	Sell	2,512,453 -841,996	-25%	-$1.45M	0.06%	26
2025 Q2	$4.66M	Hold	3,354,449	–	–	0.33%	25
2025 Q1	$3.66M	Hold	3,354,449	–	–	0.28%	27
2024 Q4	$3.09M	Hold	3,354,449	–	–	0.19%	32
2024 Q3	$3.52M	Sell	3,354,449 -1,075,000	-24%	-$1.35M	0.17%	33
2024 Q2	$5.18M	Sell	4,429,449 -658,809	-13%	-$921K	0.28%	34
2024 Q1	$8.8M	Sell	5,088,258 -658,809	-11%	-$1.14M	0.61%	30
2023 Q4	$10.8M	Hold	5,747,067	–	–	0.67%	30
2023 Q3	$8.1M	Buy	5,747,067 +2,469,135	+75%	+$4.34M	0.6%	30
2023 Q2	$6.41M	Hold	3,277,932	–	–	0.5%	36
2023 Q1	$6.15M	Hold	3,277,932	–	–	0.41%	40
2022 Q4	$7.54M	Hold	3,277,932	–	–	0.47%	40
2022 Q3	$8.88M	Hold	3,277,932	–	–	0.42%	40
2022 Q2	$15.3M	Hold	3,277,932	–	–	0.75%	24
2022 Q1	$17.4M	Hold	3,277,932	–	–	0.92%	19
2021 Q4	$21M	Buy	+3,277,932	New	+$31.7M	0.99%	20

Other funds holding IOBT

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Novo Holdings A/S's IOBT Position: Q1 2026 in Review

Novo Holdings A/S sold out of IO Biotech (IOBT) in Q1 2026, closing a stake of 2,512,453 shares — an estimated $1.53M sold.

Novo Holdings A/S first reported a position in IOBT in Q4 2021 and held it in 17 quarters. The position peaked at $21M in Q4 2021. 12 funds tracked by Wall St. Rank hold IOBT as of Q1 2026.

Novo Holdings A/S reported no remaining IO Biotech position as of Q1 2026 after selling out during the quarter.
Novo Holdings A/S sold 2,512,453 IO Biotech shares in Q1 2026, an estimated $1.53M.
Novo Holdings A/S first reported a position in IO Biotech in Q4 2021 and held it in 17 quarters.
Novo Holdings A/S's IO Biotech position peaked at $21M in Q4 2021.
12 funds tracked by Wall St. Rank held IO Biotech as of Q1 2026.

Based on Novo Holdings A/S's 13F filing for Q1 2026, filed 15 May 2026.